Impact of a higher radiation dose on local control and survival in breast-conserving therapy
of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
Klsler, "Breast-conserving therapy
with partial or whole breast irradiation: tenyear results of the Budapest randomized trial," Radiotherapy & Oncology, vol.
Schnitt, "Outcome after breast-conserving therapy
for patients with stage I or II musinous, medullary, or tubular breast carcinoma," International Journal of Radiation Oncology Biology Physics, vol.
Angiosarcoma after breast-conserving therapy
: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART).
They cover evolution of oncoplastic surgery, principles and considerations of oncoplastic breast conservation, immediate partial breast reconstruction, correction of the breast-conserving therapy
deformity: delayed partial breast reconstruction, and outcomes and future directions.
in breast cancer patients --a 12-year experience.
Quality of life over 5 years in women with breast cancer after breast-conserving therapy
versus mastectomy: a population-based study.
CHICAGO -- Women with clinical early-stage breast cancer and a positive sentinel lymph node who receive breast-conserving therapy
can safely skip an axillary lymph node dissection (ALND), and therefore avoid its associated morbidity, confirms long-term follow-up of the Z00 11 trial conducted by the American College of Surgeons Oncology Group and the Alliance for Clinical Trials in Oncology.
When compared with breast-conserving therapy
, no significant improvement in survival was found for women undergoing CPM.
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy
in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
Mastectomy versus breast-conserving therapy
in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute.
(BCT), consisting of lumpectomy followed by radiotherapy, has become the standard form of treatment for invasive breast carcinomas up to 4-5cms and is increasingly being used for ductal carcinoma in situ (DCIS) and larger tumours.1-3 However, with BCT for large tumours, cosmetic outcome is often poor.4,5 The tumour size in relation to the breast size is one of the most important factors when attempting to obtain a cosmetically favourable result.